These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 22433332)

  • 1. The evolution of cervical screening and the specialty of obstetrics and gynecology.
    Chelmow D; Waxman A; Cain JM; Lawrence HC
    Obstet Gynecol; 2012 Apr; 119(4):695-9. PubMed ID: 22433332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical cancer screening among women who attend sexually transmitted diseases (STD) clinics: background paper for 2010 STD Treatment Guidelines.
    Datta SD; Saraiya M
    Clin Infect Dis; 2011 Dec; 53 Suppl 3():S153-9. PubMed ID: 22080268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
    Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
    Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical cancer screening in the 21st century: is it time to retire the PAP smear?
    Wright TC
    Clin Obstet Gynecol; 2007 Jun; 50(2):313-23. PubMed ID: 17513921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of human papilloma virus testing in cervical cancer prevention.
    Fey MC; Beal MW
    J Midwifery Womens Health; 2004; 49(1):4-13. PubMed ID: 14710135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of adding human papilloma virus testing to a managed care cervical cancer screening program.
    Lonky NM; Hunter MI; Sadeghi M; Edwards G; Bajamundi K; Monk BJ
    J Low Genit Tract Dis; 2007 Oct; 11(4):258-64. PubMed ID: 17917570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
    Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
    Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening.
    Wright TC; Schiffman M; Solomon D; Cox JT; Garcia F; Goldie S; Hatch K; Noller KL; Roach N; Runowicz C; Saslow D
    Obstet Gynecol; 2004 Feb; 103(2):304-9. PubMed ID: 14754700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing for human papillomavirus in cervical cancer screening: a review of indications and methodology.
    Nishino HT; Tambouret RH; Wilbur DC
    Cancer Cytopathol; 2011 Aug; 119(4):219-27. PubMed ID: 21717588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current techniques in screening for cervical cancer in Spain: updated recommendations.
    Puig-Tintoré LM; Torné A; Alonso I
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S8-S10. PubMed ID: 18606440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era.
    Tota J; Mahmud SM; Ferenczy A; Coutlée F; Franco EL
    Sex Health; 2010 Sep; 7(3):376-82. PubMed ID: 20719230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer screening: Less testing, smarter testing.
    Jin XW; Sikon A; Yen-Lieberman B
    Cleve Clin J Med; 2011 Nov; 78(11):737-47. PubMed ID: 22049541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer screening in the early post vaccine era.
    Waxman AG
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):537-48; vii. PubMed ID: 19061815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updated approach to screening for cervical cancer in older women.
    Celentano DD
    Geriatrics; 1988 Apr; 43(4):37-8, 40-4, 48. PubMed ID: 2832258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the role of education in women's knowledge and acceptance of adjunct high-risk human Papillomavirus testing for cervical cancer screening.
    Papa D; Moore Simas TA; Reynolds M; Melnitsky H
    J Low Genit Tract Dis; 2009 Apr; 13(2):66-71. PubMed ID: 19387125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing.
    Howell LP; Gurusinghe S; Tabnak F; Sciortino S
    Cancer Detect Prev; 2009; 32(5-6):372-9. PubMed ID: 19264426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus and cervical disease in adolescents.
    Guido R
    Clin Obstet Gynecol; 2008 Jun; 51(2):290-305. PubMed ID: 18463460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What's new in gynecology and obstetrics].
    Jaton C; Meyer-Hamme U; Petignat P; Kayser B; Irion O; Boulvain M
    Rev Med Suisse; 2012 Jan; 8(324):92-5. PubMed ID: 23185816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening Women at High Risk for Cervical Cancer: Special Groups of Women Who Require More Frequent Screening.
    Vegunta S; Files JA; Wasson MN
    Mayo Clin Proc; 2017 Aug; 92(8):1272-1277. PubMed ID: 28778260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cross-sectional survey examining clinician characteristics, practices, and attitudes associated with adoption of the 2019 American Society for Colposcopy and Cervical Pathology risk-based management consensus guidelines.
    Vadaparampil ST; Fuzzell LN; Brownstein NC; Fontenot HB; Lake P; Michel A; McIntyre M; Whitmer A; Perkins RB
    Cancer; 2023 Sep; 129(17):2671-2684. PubMed ID: 37221653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.